Quote:
Originally Posted by rubecube
There's nothing to suggest that moving to a public system or partial public system would stifle innovation. At the end of the day, the U.S. is still going to be able to outbid other countries for the best and brightest minds.
|
The theory would be, I imagine, that if you have a public system then you have the decision makers about what's legal and what isn't suddenly holding the purse strings, more or less directly. That will incentivize them to drive costs down, which is good. However, it will incentivize driving down the cost of drugs and treatments, which in turn decreases the profitability of developing new drugs and treatments, which means there will be less investment in developing those new drugs and treatments. If the moment your new wonder drug hits the market, you have to sell it for cheap or allow your competitors to make knock-off versions to compete with yours, there's no good reason to spend ten billion dollars coming up with it in the first place.
It makes sense, it's just something you have to figure out a way around.